MSc Drug Design UCL

10/10/2024

https://www.ucl.ac.uk/news/2024/oct/ucl-celebrates-two-more-nobel-prize-laureates

Congratulations to AI pioneers Sir Demis Hassabis CBE and Professor Geoffrey Hinton, who have both won Nobel Prizes this week, taking the total of Nobel laureates from the UCL community to 32.

04/06/2024

UCL has been ranked 9th best university in the world for the second year in a row, marking UCL’s 13th year among the top 10 universities worldwide, in the 2025 QS World University Rankings! 👏

The rankings specifically highlight the strength of UCL’s academic and employer reputation, and named UCL second in the world for the strength of its international research network, which takes into account the diversity and impact of our partnerships across the world.

QS World University Rankings

https://www.ucl.ac.uk/news/2024/jun/ucl-ranked-ninth-best-university-world

27/04/2023

Watch our winning video from PGT students.

05/04/2023

Wishing everyone a relaxing Spring break!

UCL will be closed from 5.30pm on Wednesday 5 April to 9am on Thursday 13 April, but some study spaces will remain open on campus and support services for students will continue to be available: http://bit.ly/3m6VSlY

24/03/2023

It's the last day of term today! 😀

Enjoy the break and good luck with any remaining assessments.

Remember we have guidance, tips and resources to help you succeed in your upcoming exams: https://www.ucl.ac.uk/students/support-and-wellbeing/exam-season-toolkit

28/07/2022

https://www.globenewswire.com/news-release/2022/06/16/2464027/0/en/Lenire-Biosciences-Completes-License-Agreement-with-University-College-London-for-VSN16R-A-Novel-Clinical-Candidate-Treatment-for-Fragile-X-Syndrome.html

SAN DIEGO, June 16, 2022 (GLOBE NEWSWIRE) -- Lenire Biosciences Inc., a biopharmaceutical company developing novel treatments for Fragile X Syndrome...

09/06/2022

https://www.ucl.ac.uk/news/2022/jun/ucl-ranked-eighth-best-university-globally-second-year-running

UCL has again been ranked among the top 10 universities in the world according to the 2023 QS World University Rankings.

12/05/2022

https://www.ucl.ac.uk/news/2022/may/ucl-comes-second-uk-research-power

The excellence of research at UCL and its positive real-world impact has improved since 2014, according to the Research Excellence Framework 2021 (REF) assessment results announced today.

12/04/2022

Wishing everyone a relaxing Easter break!
UCL will be closed from 5.30pm Tuesday 12 April to 9am Tuesday 19 April but some study spaces will remain open on campus and support services for students will continue to be available: https://www.ucl.ac.uk/estates/news/2022/mar/ucl-easter-closure-2022

06/04/2022

UCL currently has nine subject areas ranked in the global top 10 in the latest QS World University Rankings 2022, including IOE, UCL's Faculty of Education and Society which maintained its position as first in the world for Education for the ninth year in a row!

#1 in Education - IOE, UCL's Faculty of Education and Society
#3 in Architecture & the Built Environment - The Bartlett
#3 in Archaeology - UCL Institute of Archaeology
#4 in Anthropology - UCL Anthropology
#4 in Pharmacy & Pharmacology - UCL School of Pharmacy
#6 in Anatomy & Physiology - UCL Division of Biosciences
#7 in Medicine - UCL Faculty of Medical Science
#7 in Psychology - UCL PALS
#9 in Geography - UCL Department of Geography.

See how all of UCL's subjects ranked: https://www.ucl.ac.uk/news/2022/apr/ucl-subjects-jump-world-university-rankings

30/03/2022

Registrations for our 2022 graduation ceremonies – taking place on campus – are now open!

If you're due to graduate this year, please keep an eye on your inbox as we'll be sending out information very soon. You can register up until 21 April: https://www.ucl.ac.uk/graduation/

21/03/2022

https://www.ucl.ac.uk/news/2022/mar/world-first-cjd-treatment-shows-promising-early-results

A world-first treatment for Creutzfeldt-Jakob disease (CJD), developed by scientists at the Medical Research Council (MRC) Prion Unit at UCL, has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation.